Flavonoids in prevention of diseases with respect to modulation of Ca-pump function

Interdisciplinary Toxicology

Volumn 4, Issue 3, 2011, Pages 114-124

  Horáková, Lubica ^a  

^a INSTITUTE OF EXPERIMENTAL PHARMACOLOGY AND TOXICOLOGY   (Slovakia)

Author keywords

Ca 2+ ATPases in aging and diseases; Flavonoids; Oxidative nitrosative stress

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); AGLYCONE; CATECHIN; CURCUMIN; CYSTEINE; DOXORUBICIN; EPICATECHIN; EPICATECHIN GALLATE; EPIGALLOCATECHIN; EPIGALLOCATECHIN GALLATE; FLAVONOID; GREEN TEA EXTRACT; POLYPHENOL; PROANTHOCYANIDIN; REACTIVE OXYGEN METABOLITE; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; TYROSINE;

AGING; ALZHEIMER DISEASE; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; BREAST CANCER; CANCER CELL; CANCER CHEMOTHERAPY; CARDIOMYOPATHY; CARDIOTOXICITY; DEMENTIA; DRUG PROTEIN BINDING; DRUG STRUCTURE; ENZYME ACTIVITY; ENZYME CONFORMATION; GLYCOSYLATION; HEART PROTECTION; HUMAN; ISOMER; NITRATION; NITROSATIVE STRESS; NONHUMAN; OXIDATION; OXIDATIVE STRESS; PARKINSON DISEASE; PROTEIN PROCESSING; PROTEIN TARGETING; REVIEW; SCAVENGING SYSTEM; TEA; VASCULAR DISEASE;

EID: 80055081411     PISSN: 13376853     EISSN: 13379569     Source Type: Journal    
DOI: 10.2478/v10102-011-0019-5     Document Type: Review

References (79)

1. Adachi T, Matsui R, Weisbrod RM, Najibi S, Cohen RA. (2001). Reduced sarco/endoplasmic reticulum Ca(2+). uptake activity can account for the reduced response to NO, but not sodium nitroprusside, in hypercholesterolemic rabbit aorta. Circulation 104: 1040-1045. (Pubitemid 32803882)
2. Adachi T, Matsui R, Xu S, Kirber M, Lazar HL, Sharov VS, Schöneich C, Cohen RA. (2002). Antioxidant improves smooth muscle sarco/endoplasmic reticulum Ca(2+)-ATPase function and lowers tyrosine nitration in hypercholesterolemia and improves nitric oxide-induced relaxation. Circ Res 90: 1114-1121. (Pubitemid 34627911)
3. Adachi T, Weisbrod RM, Pimentel DR, Ying J, Sharov VS, Schöneich C, Cohen RA. (2004). S-Glutathiolation by peroxynitrite activates SERCA during arterial relaxation by nitric oxide. Nat Med 10: 1200-1207. (Pubitemid 39540436)
4. Adachi T. (2010). Modulation of vascular sarco/endoplasmic reticulum calcium ATPase in cardiovascular pathophysiology. Adv Pharmacol 59: 165-195. Review.
5. Amić D, Davidović-Amić D, Beslo D, Rastija V, Lucić B, Trinajstić N. (2007). SAR and QSAR of the antioxidant activity of flavonoids. Curr Med Chem 14: 827-845. Review. (Pubitemid 46477715)
6. Bast A, Haenen GR, Bruynzeel AM, Van der Vijgh WJ. (2007). Protection by flavonoids against anthracycline cardiotoxicity: from chemistry to clinical trials. Cardiovasc Toxicol 7: 154-159. Review. (Pubitemid 47339864)
7. Bettuzzi S, Brausi M, Rizzi F, Castagnetti G, Peracchia G, Corti A. (2006). Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: a preliminary report from a one-year proof-of-principle study. Cancer Res 66: 1234-40. (Pubitemid 43165995)
8. Bigelow DJ. (2009). Nitrotyrosine-modifi ed SERCA2: a cellular sensor of reactive nitrogen species. Pflugers Arch 457: 701-710.
9. 2+ pumps by curcumin. Curcumin putatively stabilizes the interaction between the nucleotide-binding and phosphorylation domains in the absence of ATP. Eur J Biochem 268: 6318-6327. (Pubitemid 33132054)
10. Burda S, Oleszek W. (2001). Antioxidant and antiradical activities of flavonoids. J Agric Food Chem 49: 2774-2779. (Pubitemid 32826067)
11. Cao G, Sofi c E, Prior RL. (1997). Antioxidant and prooxidant behavior of flavonoids: structure-activity relationships. Free Radic Biol Med 22: 749-60. (Pubitemid 27058337)
12. Clement Y. (2009). Can green tea do that? A literature review of the clinical evidence. Prev Med 49: 83-87. Review.
13. Chen B, Jones TE, Bigelow DJ. (1999). The nucleotide-binding site of the sarcoplasmic reticulum Ca-ATPase is conformationally altered in aged skeletal muscle. Biochemistry 38:14887-14896.
14. Choi EH, Chang HJ, Cho JY, Chun HS. (2007). Cytoprotective Effect of anthocyanins against doxorubicin-induced toxicity in H9c2 cardiomyocytes in relation to their antioxidant activities. Food Chem Toxicol 45: 1873-1881. (Pubitemid 47243642)
15. Chyu KY, Babbidge SM, Zhao X, Dandillaya R, Rietveld AG, Yano J, Dimayuga P, Cercek B, Shah PK. (2004). Diff erential effects of green tea-derived catechin on developing versus established atherosclerosis in apolipoprotein E-null mice. Circulation 109: 2448-2453. (Pubitemid 38679566)
16. Cohen RA and Adachi T. (2006). Nitric-oxide-induced vasodilatation: Regulation by Physiologic S-glutathiolation and pathologic oxidation of the sarcoplasmic endoplasmic reticulum calcium ATPase. TCM 16: 109-114.
17. Croft KD. (2006). The chemistry and biological effects of flavonoids and phenolic acids. Ann NY Acad Sci 854: 435-442.
18. Dremina ES, Sharov VS, Davies MJ, Schöneich C. (2007). Oxidation and inactivation of SERCA by selective reaction of cysteine residues with amino acid peroxides. Chem Res Toxicol 20: 1462-1469. (Pubitemid 350057214)
19. Drieu K. (1986). Preparation and defi nition of the extract of Ginkgo biloba. Presse Médicale 15: 1455-1457. (Pubitemid 16018103)
20. Dyer JL, Khan SZ, Bilmen JG, Hawtin SR, Wheatley M, Javed MU, Michelangeli F. (2002). Curcumin: a new cell-permeant inhibitor of the inositol 1,4,5-trisphosphate receptor. Cell Calcium 31: 45-52. (Pubitemid 34189556)
21. East JM. (2000). Sarco(endo)plasmic reticulum calcium pumps: recent advances in our understanding of structure/function and biology. Mol Membr Biol 17: 189-200. (Pubitemid 32267316)
22. Erlund I, Silaste ML, Alfthan G, Rantala M, Kesäniemi YA, Aro A. (2002). Plasma concentrations of the flavonoids hesperetin, naringenin and quercetin in human subjects following their habitual diets, and diets high or low in fruit and vegetables. Eur J Clin Nutr 56: 891-898.
23. Hagerman AE, Dean RT, Davies MJ. (2003). Radical chemistry of epigallocatechin gallate and its relevance to protein damage. Arch Biochem Biophys 14: 115-120. (Pubitemid 36555452)
24. Hanasaki Y, Ogawa S, Fukui S. (1994). The correlation between active oxygens scavenging and antioxidative effects of flavonoids. Free Radic Biol Med 16: 845-50. (Pubitemid 24193534)
25. Heim KE, Tagliaferro AR, Bobilya DJ. (2002). Flavonoid antioxidants: chemistry, metabolism and structure-activity relationships. J Nutr Biochem 13: 572-584. (Pubitemid 35246546)
26. Hodgson JM, Croft KD. (2010). Tea flavonoids and cardiovascular health. Mol Aspects Med 31: 495-502. Review.
27. 2+ ATPase (SERCA). inhibition. J Bioenerg Biomembr 37: 365-8. Review. (Pubitemid 43725159)
28. Ishige K, Schubert D, Sagara Y. (2001). Flavonoids protect neuronal cells from oxidative stress by three distinct mechanisms. Free Radical Biology & Medicine 30: 433-446. (Pubitemid 32155542)
29. Kamihira M, Nakazawa H, Kira A, Mizutani Y, Nakamura M, Nakayama T. (2008). Interaction of tea catechins with lipid bilayers investigated by a quartz-crystal microbalance analysis. Biosci Biotechnol Biochem 72: 1372-1375. (Pubitemid 351872500)
30. Knyushko TV, Sharov VS, Williams TD, Schöneich C. and Bigelow DJ. (2005). 3-Nitrotyrosine-modifi cation of SERCA2a in the aging heart: a distinct signature of cellular redox environment. Biochemistry 44: 13071-13081. (Pubitemid 41377287)
31. Kuhar M, Sen S, Singh N. (2006). Role of mitochondria in quercetin-enhanced chemotherapeutic response in human non-small cell lung carcinoma H-520 cells. Anticancer Res 26: 1297-1303.
32. Lancel S, Qin F, Lennon SL, Zhang J, Tong X, Mazzini MJ, Kang YJ, Siwik DA, Cohen RA, Colucci WS. (2010). Oxidative posttranslational modifi cations mediate decreased SERCA activity and myocyte dysfunction in Galphaqoverexpressing mice. Circ Res 107: 228-232.
33. Leung HW, Kuo CL, Yang WH, Lin CH, Lee HZ. (2006). Antioxidant enzymes activity involvement in luteolin-induced human lung squamous carcinoma CH27 cell apoptosis. Eur J Pharmacol 534: 12-18.
34. 2+-ATPases. J Biol Chem 272: 28815-28828.
35. Mandel SA, Amit T, Weinreb O, Youdim MB. (2011). Understanding the broadspectrum neuroprotective action profi le of green tea polyphenols in aging and neurodegenerative diseases. J Alzheimers Dis 25(2): 187-208.
36. Martín MA, Serrano AB, Ramos S, Pulido MI, Bravo L, Goya L. (2010). Cocoa flavonoids up-regulate antioxidant enzyme activity via the ERK1/2 pathway to protect against oxidative stress-induced apoptosis in HepG2 cells. J Nutr Biochem 21: 196-205.
37. Mulvihill EE, Huff MW. (2010). Antiatherogenic properties of flavonoids: implications for cardiovascular health. Can J Cardiol 26(Suppl A): 17A-21A. Review.
38. Nagata H, Takekoshi S, Takagi T, Honma T, Watanabe K. (1999). Antioxidative action of flavonoids, quercetin and catechin, mediated by the activation of glutathione peroxidase. Tokai J Exp Clin Med 24: 1-11. (Pubitemid 29403853)
39. +, K(+)-ATPase by favoring the E1 conformation. Biochem Pharmacol 78: 1069-74.
40. 2+-ATPase by flavonoids: a quantitative structure-activity relationship study. IUBMB Life 60: 853-858.
41. Pacher P, Beckman JS, Liaudet L. (2007). Nitric oxide and peroxynitrite in health and disease. Physiol Rev 87: 315-424. Review. (Pubitemid 46217686)
42. Packer L, Rimbach G, Virgili F. (1999). Antioxidant activity and biologic properties of a procyanidin-rich extract from pine (Pinus maritima). bark, pycnogenol. Free Radical Biology & Medicine 27: 704-724. (Pubitemid 29408657)
43. Procházková D, Boušová I, Wilhelmová N. (2011). Antioxidant and prooxidant properties of flavonoids. Fitoterapia 82: 513-523.
44. Ramos S. (2007). Effects of dietary flavonoids on apoptotic pathways related to cancer chemoprevention. J Nutr Biochem 18: 427-442. (Pubitemid 46874924)
45. 2+-ATPase and mu-calpain activity are altered in type 2 diabetes mellitus and restored by rosiglitazone. Circulation 117: 52-60. (Pubitemid 350291181)
46. 2+Mg2+)-adenosine triphosphatase of sarcoplasmic reticulum. Biochim Biophys Acta 874: 305-311. (Pubitemid 17216678)
47. Rice-Evans CA, Miller NJ, Paganga G. (1996). Structure-antioxidant activity relationships of flavonoids and phenolic acids. Free Radic Biol Med 20: 933-956. (Pubitemid 26157509)
48. Rizvi SI, Zaid MA. (2005). Impairment of sodium pump and Na/H exchanger in erythrocytes from non-insulin dependent diabetes mellitus patients: effect of tea catechins. Clin Chim Acta 354: 59-67.
49. Rohdewald P. (2002). A review of the French maritime pine bark extract (Pycnogenol). a herbal medication with a diverse clinical pharmacology. Review. International Journal of Clinical Pharmacology and Therapeutics 40: 158-168. (Pubitemid 34296383)
50. Sastre J, Millan A, De La Asuncion JG, Pla JG, Pallardo FV, Ó Connor E, Martin JA, Droy-Lefaix MT, Viña J. (1998). A Ginkgo biloba extract (EGb 761). prevents mitochondrial aging by protecting against oxidative stress. Free Radical Biology & Medicine 24: 298-304. (Pubitemid 28008808)
51. Schroeter H, Williams RJ, Matin R, Iversen L, Rice-Evans CA. (2000). Phenolic antioxidants attenuate neuronal cell death following uptake of oxidized low-density lipoprotein. Free Radical Biology & Medicine 29: 1222-1233.
52. Schimmel KJ, Richel DJ, van den Brink RB, Guchelaar HJ. (2004). Cardiotoxicity of cytotoxic drugs. Cancer Treat Rev 30: 181-191. Review. (Pubitemid 38418056)
53. Selvendiran K, Koga H, Ueno T, Yoshida T, Maeyama M, Torimura T, Yano H, Kojiro M, Sata M. (2006). Luteolin promotes degradation in signal transducer and activator of transcription 3 in human hepatoma cells: an implication for the antitumor potential of flavonoids. Cancer Res 66: 4826-4834.
54. Sharov VS, Dremina ES, Galeva NA, Williams TD, Schöneich C. (2006). Quantitative mapping of oxidation-sensitive cysteine residues in SERCA in vivo and in vitro by HPLC-electrospray-tandem MS: selective protein oxidation during biological aging. Biochem J 394: 605-615.
55. Sheng R, Gu ZL, Xie ML, Zhou WX, Guo CY. (2007). EGCG inhibits cardiomyocyte apoptosis in pressure overload-induced cardiac hypertrophy and protects cardiomyocytes from oxidative stress in rats. Acta Pharmacol Sin 28: 191-201. (Pubitemid 46155536)
56. 2+ + Mg2+)-ATPase of sarcoplasmic reticulum. J Biol Chem 256: 887-892. (Pubitemid 11103044)
57. 2+-ATPase activity from rabbit skeletal muscle. Neuroendocrinology Letters 27: 164-167. (Pubitemid 46534364)
58. Štrosová MK, Karlovská J, Žiž ková P, Kwolek-Mirek M, Poništ S, Spickett CM, Horáková ?. (2011). Modulation of sarcoplasmic/endoplasmic reticulum Ca(2+)-ATPase activity and oxidative modifi cation during the development of adjuvant arthritis. Arch Biochem Biophys 511: 40-47.
59. 2+-ATPase sarcoplasmic reticulum by HOCl and HNE and protective Effect of some antioxidants. Biofactors 23: 111-116. (Pubitemid 41750533)
60. Suganuma M, Saha A, Fujiki H. (2011). New cancer treatment strategy using combination of green tea catechins and anticancer drugs. Cancer Sci 102: 317-323. Review.
61. Sun C, Fu J, Chen J, Jiang L, Pan Y. (2010). On-line HPLC method for screening of antioxidants against superoxide anion radical from complex mixtures. J Sep Sci 33: 1018-23.
62. Taguchi K, Kobayashi T, Hayashi Y, Matsumoto T, Kamata K. (2007). Enalapril improves impairment of SERCA-derived relaxation and enhancement of tyrosine nitration in diabetic rat aorta. Eur J Pharmacol 556: 121-128. (Pubitemid 46074013)
63. Taubert D, Breitenbach T, Lazar A, Censarek P, Harlfi nger S, Berkels R, Klaus W, Roesen R. (2003). Reaction rate constants of superoxide scavenging by plant antioxidants. Free Radic Biol Med 35: 1599-1607. (Pubitemid 37532911)
64. Tipoe GL, Leung TM, Hung MW, Fung ML. (2007). Green tea polyphenols as an antioxidant and anti-inflammatory agent for cardiovascular protection. Cardiovasc Hematol Disord Drug Targets 7: 135-144. Review. (Pubitemid 47024129)
65. Tong X, Evangelista A, Cohen RA. (2010). Targeting the redox regulation of SERCA in vascular physiology and disease. Curr Opin Pharmacol 10: 133-138.
66. Tsujimoto I, Hikoso S, Yamaguchi O, Kashiwase K, Nakai A, Takeda T, Watanabe T, Taniike M, Matsumura Y, Nishida K, Hori M, Kogo M, Otsu K. (2005). The antioxidant edaravone attenuates pressure overload-induced left ventricular hypertrophy. Hypertension 45: 921-926. (Pubitemid 40628938)
67. Townsend PA, Scarabelli TM, Pasini E, Gitti G, Menegazzi M, Suzuki H, Knight RA, Latchman DS, Stephanou A. (2004). Epigallocatechin-3-gallate inhibits STAT-1 activation and protects cardiac myocytes from ischemia/reperfusion- induced apoptosis. FASEB J 18:1621-1623. (Pubitemid 39561653)
68. 2+-ATPase is associated with reduced enzyme activity in rat muscle. Am J Physiol Regul Integr Comp Physiol 281: R1681-1688.
69. 2+ homeostasis and apoptotic resistance of neuroendocrine-diff erentiated prostate cancer cells. Cell Death Diff er 11: 321-330. (Pubitemid 38313141)
70. 2+-ATPase in skeletal muscle. Biochem J 340: 657-669. (Pubitemid 29312862)
71. Viner RI, Williams TD. and Schöneich C (1999b). Peroxynitrite modifi cation of protein thiols: oxidation, nitrosilation, and S-glutathiolation of functionally important cysteine residue(s). in the sarcoplasmic reticulum Ca-ATPase. Biochemistry 38: 12408-12415.
72. 2+-ATPase oxidized by hypochloric acid and peroxinitrite. Neuroendocrinology Letters 30: 148-151.
73. Voss P, Engels M, Štrosova M, Grune T, Horakova ?. (2008). Protective Effect of antioxidants against sarcoplasmic reticulum (SR). oxidation by Fenton reaction, however without prevention of Ca-pump activity. Toxicology In vitro 22: 1726-1733.
74. 2+,Mg(2+)-ATPase. FEBS Lett 304: 109-13.
75. Williams SB, Cusco JA, Roddy MA, Johnstone MT, Creager MA. (1996). Impaired nitric oxide-mediated vasodilation in patients with non-insulin-dependent diabetes mellitus. J Am Coll Cardiol 27: 567-74. (Pubitemid 26081917)
76. Winkel-Shirley B. (2001). Flavonoid biosynthesis: a colorful model for genetics, biochemistry, cell biology and biotechnology. Plant Physiol 126: 485-493. (Pubitemid 32566604)
77. Yang CS, Wang X. (2010). Green tea and cancer prevention. Nutr Cancer 62: 931-937. Review.
78. Ying J, Sharov V, Xu S, Jiang B, Gerrity R, Schöneich C, Cohen RA. (2008). Cysteine-674 oxidation and degradation of sarcoplasmic reticulum Ca(2+). ATPase in diabetic pig aorta. Free Radic Biol Med 45: 756-62.
79. Zheng J, Lee HC, Bin Sattar MM, Huang Y, Bian JS. (2011). Cardioprotective effects of epigallocatechin-3-gallate against doxorubicin-induced cardiomyocyte injury. Eur J Pharmacol 652: 82-88.